Cargando…
The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
Interferon (IFN) shows no specificity in inhibiting the growth of colonies of myeloid leukaemia blasts in culture as compared to normal haemopoietic precursors, but does reduce the self-renewal capacity of myeloblasts. We have tested the ability of IFN to slow the leukocyte doubling time (Ldt) and t...
Autores principales: | Bergsagel, D. E., Messner, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971686/ https://www.ncbi.nlm.nih.gov/pubmed/2372493 |
Ejemplares similares
-
Busulphan in the Treatment of Chronic Granulocytic Leukaemia
por: Bridges, J. M., et al.
Publicado: (1961) -
Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016) -
Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.
por: Hoffman, R., et al.
Publicado: (1989) -
The Effect of Cysteine on the Immunosuppressive Activity of Busulphan, Cyclophosphamide and Nitrogen Mustard
por: Addison, I. E., et al.
Publicado: (1971) -
Granulocyte function in myeloblastic leukaemia.
por: Wilkinson, P. M., et al.
Publicado: (1975)